Krystal Biotech
KRYS
KRYS
23 hedge funds and large institutions have $47.6M invested in Krystal Biotech in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
+6
Holders Change %
+35.29%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
5
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
FM
Frazier Management
Seattle,
Washington
|
+$11M |
| 2 |
SST
S Squared Technology
New York
|
+$948K |
| 3 |
Renaissance Technologies
New York
|
+$891K |
| 4 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
+$527K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$403K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.65M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$1.5M |
| 3 |
TCP
Tourbillon Capital Partners
New York
|
-$1.13M |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$1.03M |
| 5 |
Millennium Management
New York
|
-$383K |
